Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

2.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

3.3K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
3.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML.

Blood advances·2025
Same author

Constitutive IL-7 signaling promotes CAR-NK cell survival in the solid tumor microenvironment but impairs tumor control.

Journal for immunotherapy of cancer·2025
Same author

Somatic TP53 Mutations Drive T and NK Cell Dysfunction in AML and Can be Rescued by Reactivating Wild Type p53.

medRxiv : the preprint server for health sciences·2025
Same author

Mesoscopic p53-rich clusters represent a new class of protein condensates.

Biophysics reviews·2025
Same author

Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells.

Science advances·2025
Same author

Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers.

Nature·2024

相关实验视频

Updated: Sep 13, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

692

TIGIT通过调节免疫突触强度来影响固体瘤微环境中的CAR NK细胞效应器功能.

Ishwar Navin1, Matthew Dysthe2, Prashant S Menon3

  • 1Baylor College of Medicine, Houston, TX, United States.

Cancer immunology research
|July 30, 2025
PubMed
概括

从仿真抗原受体 (CAR) -NK细胞中删除TIGIT受体可以提高它们对抗固体瘤的能力. 这种修改改善了CAR-NK细胞在免疫抑制瘤微环境中的持久性和有效性.

更多相关视频

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.9K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.1K

相关实验视频

Last Updated: Sep 13, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

692
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.9K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.1K

科学领域:

  • 免疫学 免疫学 免疫学
  • 癌症生物学 癌症生物学
  • 细胞疗法细胞疗法

背景情况:

  • 化学抗原受体 (CAR) -NK细胞疗法显示出对抗血液癌症的前景.
  • 固体瘤产生免疫抑制的微环境,限制了CAR-NK细胞的有效性.
  • 作为NK细胞抑制受体的TIGIT在对抗固体瘤的CAR-NK细胞功能中的作用尚不清楚.

研究的目的:

  • 在固体瘤模型中研究TIGIT表达对GD2向CAR-NK细胞抗瘤活性的影响.
  • 在免疫抑制环境中比较TIGIT删除与TIGIT表达CAR-NK细胞的疗效.

主要方法:

  • 使用了模仿固体瘤微环境 (TiME) 的共同培养系统和体内异种移植.
  • 对抗瘤活性,扩张和持久性进行了比较,比较了表达TIGIT和删除TIGIT的人类GD2.CAR-NK细胞.
  • 机械学研究探讨了TIGIT在细胞粘附,突触形成和连环杀伤中的作用.

主要成果:

  • 被TIGIT删除的GD2.CAR-NK细胞在TIGIT结合体丰富的瘤环境中表现出显著的抗瘤活性,扩张和持久性.
  • 在类似的条件下,表达TIGIT的CAR-NK细胞显示出抗瘤功能受损.
  • 通过降低细胞粘附分子的调节,降低激发和突触持续时间,增强连续杀伤,提高瘤破坏效率,TIGIT删除改善了瘤控制.

结论:

  • 在调节对抗固体瘤的CAR-NK细胞活性方面,TIGIT发挥了新的,非正规的作用.
  • 从CAR-NK细胞中删除TIGIT可以克服固体瘤中的抑制性受体介导抵抗.
  • 针对TIGIT提供了一种潜在的策略,以提高对固体瘤的CAR-NK细胞疗法的疗效.